Mild elevation of N-acetylaspartic acid and macrocephaly

Diagnostic problem

Sankar Surendran, Fiona J. Bamforth, Alicia Chan, Stephen K. Tyring, Stephen I. Goodman, Reuben Matalon

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Patients with slightly increased excretion of N-acetylaspartic acid in urine, together with macrocephaly, present a dignostic dilemma for Canavan's disease. We describe a 13-year-old male patient with macrocephaly, mild developmental delay, increased signal intensity in the basal ganglia bilaterally, partial cortical blindness, and retinitis pigmentosa. Although the clinical course and magnetic resonance imaging findings did not resemble typical Canavan's disease, N-acetylaspartic acid excretion in the patient's urine was slightly elevated, 99.90 ± 4.00 μg/mg creatinine, whereas the normal control range was < 83 μg/mg creatinine. Cultured skin fibroblasts from the patient showed no aspartoacylase activity. Cloning of genomic DNA isolated from the patient's fibroblasts showed an intronic mutation, specifically deletion of -2A and -3C at the acceptor site of exon 3 and disrupting the normal splicing of the gene. A second mutation was found in exon 6, 863 A→G in aspartoacylase complementary DNA, causing a tyrosine-to-cysteine (Y288C) amino acid substitution. Expression of the mutation on exon 6 showed normal aspartoacylase activity. These data suggest that expression of the mutation may help to understand the enzyme defect in patient with slightly increased N-acetylaspartic acid excretion.

Original languageEnglish (US)
Pages (from-to)809-812
Number of pages4
JournalJournal of Child Neurology
Volume18
Issue number11
StatePublished - Nov 2003

Fingerprint

Megalencephaly
Canavan Disease
Exons
Mutation
Creatinine
Fibroblasts
Cortical Blindness
Urine
Retinitis Pigmentosa
Sequence Deletion
Amino Acid Substitution
Basal Ganglia
Cysteine
Tyrosine
N-acetylaspartate
Organism Cloning
Reference Values
Complementary DNA
Magnetic Resonance Imaging
Skin

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Surendran, S., Bamforth, F. J., Chan, A., Tyring, S. K., Goodman, S. I., & Matalon, R. (2003). Mild elevation of N-acetylaspartic acid and macrocephaly: Diagnostic problem. Journal of Child Neurology, 18(11), 809-812.

Mild elevation of N-acetylaspartic acid and macrocephaly : Diagnostic problem. / Surendran, Sankar; Bamforth, Fiona J.; Chan, Alicia; Tyring, Stephen K.; Goodman, Stephen I.; Matalon, Reuben.

In: Journal of Child Neurology, Vol. 18, No. 11, 11.2003, p. 809-812.

Research output: Contribution to journalArticle

Surendran, S, Bamforth, FJ, Chan, A, Tyring, SK, Goodman, SI & Matalon, R 2003, 'Mild elevation of N-acetylaspartic acid and macrocephaly: Diagnostic problem', Journal of Child Neurology, vol. 18, no. 11, pp. 809-812.
Surendran S, Bamforth FJ, Chan A, Tyring SK, Goodman SI, Matalon R. Mild elevation of N-acetylaspartic acid and macrocephaly: Diagnostic problem. Journal of Child Neurology. 2003 Nov;18(11):809-812.
Surendran, Sankar ; Bamforth, Fiona J. ; Chan, Alicia ; Tyring, Stephen K. ; Goodman, Stephen I. ; Matalon, Reuben. / Mild elevation of N-acetylaspartic acid and macrocephaly : Diagnostic problem. In: Journal of Child Neurology. 2003 ; Vol. 18, No. 11. pp. 809-812.
@article{633920190c2c47d99473e2748440f02f,
title = "Mild elevation of N-acetylaspartic acid and macrocephaly: Diagnostic problem",
abstract = "Patients with slightly increased excretion of N-acetylaspartic acid in urine, together with macrocephaly, present a dignostic dilemma for Canavan's disease. We describe a 13-year-old male patient with macrocephaly, mild developmental delay, increased signal intensity in the basal ganglia bilaterally, partial cortical blindness, and retinitis pigmentosa. Although the clinical course and magnetic resonance imaging findings did not resemble typical Canavan's disease, N-acetylaspartic acid excretion in the patient's urine was slightly elevated, 99.90 ± 4.00 μg/mg creatinine, whereas the normal control range was < 83 μg/mg creatinine. Cultured skin fibroblasts from the patient showed no aspartoacylase activity. Cloning of genomic DNA isolated from the patient's fibroblasts showed an intronic mutation, specifically deletion of -2A and -3C at the acceptor site of exon 3 and disrupting the normal splicing of the gene. A second mutation was found in exon 6, 863 A→G in aspartoacylase complementary DNA, causing a tyrosine-to-cysteine (Y288C) amino acid substitution. Expression of the mutation on exon 6 showed normal aspartoacylase activity. These data suggest that expression of the mutation may help to understand the enzyme defect in patient with slightly increased N-acetylaspartic acid excretion.",
author = "Sankar Surendran and Bamforth, {Fiona J.} and Alicia Chan and Tyring, {Stephen K.} and Goodman, {Stephen I.} and Reuben Matalon",
year = "2003",
month = "11",
language = "English (US)",
volume = "18",
pages = "809--812",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "11",

}

TY - JOUR

T1 - Mild elevation of N-acetylaspartic acid and macrocephaly

T2 - Diagnostic problem

AU - Surendran, Sankar

AU - Bamforth, Fiona J.

AU - Chan, Alicia

AU - Tyring, Stephen K.

AU - Goodman, Stephen I.

AU - Matalon, Reuben

PY - 2003/11

Y1 - 2003/11

N2 - Patients with slightly increased excretion of N-acetylaspartic acid in urine, together with macrocephaly, present a dignostic dilemma for Canavan's disease. We describe a 13-year-old male patient with macrocephaly, mild developmental delay, increased signal intensity in the basal ganglia bilaterally, partial cortical blindness, and retinitis pigmentosa. Although the clinical course and magnetic resonance imaging findings did not resemble typical Canavan's disease, N-acetylaspartic acid excretion in the patient's urine was slightly elevated, 99.90 ± 4.00 μg/mg creatinine, whereas the normal control range was < 83 μg/mg creatinine. Cultured skin fibroblasts from the patient showed no aspartoacylase activity. Cloning of genomic DNA isolated from the patient's fibroblasts showed an intronic mutation, specifically deletion of -2A and -3C at the acceptor site of exon 3 and disrupting the normal splicing of the gene. A second mutation was found in exon 6, 863 A→G in aspartoacylase complementary DNA, causing a tyrosine-to-cysteine (Y288C) amino acid substitution. Expression of the mutation on exon 6 showed normal aspartoacylase activity. These data suggest that expression of the mutation may help to understand the enzyme defect in patient with slightly increased N-acetylaspartic acid excretion.

AB - Patients with slightly increased excretion of N-acetylaspartic acid in urine, together with macrocephaly, present a dignostic dilemma for Canavan's disease. We describe a 13-year-old male patient with macrocephaly, mild developmental delay, increased signal intensity in the basal ganglia bilaterally, partial cortical blindness, and retinitis pigmentosa. Although the clinical course and magnetic resonance imaging findings did not resemble typical Canavan's disease, N-acetylaspartic acid excretion in the patient's urine was slightly elevated, 99.90 ± 4.00 μg/mg creatinine, whereas the normal control range was < 83 μg/mg creatinine. Cultured skin fibroblasts from the patient showed no aspartoacylase activity. Cloning of genomic DNA isolated from the patient's fibroblasts showed an intronic mutation, specifically deletion of -2A and -3C at the acceptor site of exon 3 and disrupting the normal splicing of the gene. A second mutation was found in exon 6, 863 A→G in aspartoacylase complementary DNA, causing a tyrosine-to-cysteine (Y288C) amino acid substitution. Expression of the mutation on exon 6 showed normal aspartoacylase activity. These data suggest that expression of the mutation may help to understand the enzyme defect in patient with slightly increased N-acetylaspartic acid excretion.

UR - http://www.scopus.com/inward/record.url?scp=0142065924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142065924&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 809

EP - 812

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 11

ER -